Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? [electronic resource]
Producer: 20130213Description: 4944-58 p. digitalISSN:- 2219-2840
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chi-Square Distribution
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Odds Ratio
- Pancreatic Neoplasms -- drug therapy
- Survival Analysis
- Time Factors
- Treatment Outcome
- Young Adult
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review
There are no comments on this title.
Log in to your account to post a comment.